Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Safety and implementation of a phase 1 randomized GLA-SE-adjuvanted CH505TF gp120 HIV vaccine trial in newborns

medRxiv(2024)10.1101/2024.10.15.24315548Source: DataRank Database

Safety and implementation of a phase 1 randomized GLA-SE-adjuvanted CH505TF gp120 HIV vaccine trial in newborns is a research paper published in medRxiv (2024). On theSindex it has a DataRank of 0.299. It has been cited 2 times, with 2 citing works in its 1-hop citation network.

N/A

0.299DataRank · unranked

Scored on demand from live citation data

Deposits data Open Access2 citations · 2 citing works in its network

Download PDF

Cite:

Linked data & code

nct

Data availability

Repositories this paper deposited data in (declared in PubMed).

ClinicalTrials.govNCT04607408

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (11 grants)OA: greenTopics (15)IDs (PubMed, OpenAlex)Annotations (1)SDGs (1)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

DataRank Breakdown

Base Score 55%Citation Network 45%

Base Score Contribution

0.165

From this paper's citation signal

Citation Network Contribution

0.134

From 1 citing papers with measurable signal

Learn more about DataRank methodology →

Top 2 citers driving the network score

Ranked by each citer's contribution to N(p) — log1p(C_q) divided by its reference count — out of 2 citers.

A pilot feasibility study comparing large language models in extracting key information from ICU patient text records from an Irish population
Intensive Care Medicine Experimental202419 citations19 referencesContributes 0.158
Fostering Collaboration Across Nations: Report of the 6th International Neonatal and Maternal Immunization Symposium (INMIS), Costa Rica, 2024
The Pediatric Infectious Disease Journal20250 citations17 referencesContributes 0.000

Authors (23)

Kennedy Otwombe ORCID,William O. Hahn ORCID,Shi‐Yu Chen ORCID,Deirdre Josipovic,Vuyelwa Baba

Live enrichment

PubMed:39484284 OpenAlex:https://openalex.org/W4403514699

National Institutes of Health

Grant: 3UM1AI068614-15S2

CoVPN 3005 - Efficacy, Immunogenicity, and Safety of SARS-CoV-2 Recombinant Protein Vaccine with Adjuvant in Adults 18 Years of Age and Older

National Institutes of Health

Grant: 5K08AI168487-02

Immunometabolic signatures of BCG-induced neonatal trained immunity

National Institutes of Health

Grant: 3UM1AI068618-16S1

HVTN 405/HPTN 1901 (CoVPN) Characterizing SARS-CoV-2-specific Immunity in Convalescent Individuals: LC 3

National Institutes of Health

Grant: 3UM1AI068635-17S4

CoVPN 3001 - A Phase 3, Randomized, Stratified, Observer-Blind, Placebo-Controlled Study to Evaluate the Efficacy, Safety, and Immunogenicity of mRNA-1273 SARS-CoV-2 Vaccine in Adults.

National Institutes of Health

Grant: 1U19AI168643-01

Immune development in early life (IDEAL) shapes vaccine response, respiratory infectious diseaseand asthma

NIAID NIH HHS

Grant: K08 AI168487

NIAID NIH HHS

Grant: U19 AI168643

NIAID NIH HHS

Grant: UM1 AI068618

NIAID NIH HHS

Grant: UM1 AI068635

NIAID NIH HHS

Grant: UM1 AI068614

NIAID NIH HHS

Grant: HHSN272201800047C

greenLicense: cc-by-nc-nd

repositoryhttps://doi.org/10.1101/2024.10.15.24315548

GREENhttps://doi.org/10.1101/2024.10.15.24315548

repositoryhttps://doi.org/10.1101/2024.10.15.24315548

publisherhttps://syndication.highwire.org/content/doi/10.1101/2024.10.15.24315548

repositoryhttps://pubmed.ncbi.nlm.nih.gov/39484284

Fields of Study

Bacterial Infections and VaccinesImmunotherapy and Immune ResponsesNeonatal and Maternal InfectionsMedicine0303 health sciences03 medical and health sciences

Keywords

VirologyHuman immunodeficiency virus (HIV)Phase (matter)MedicineRandomized controlled trialPediatricsInternal medicineChemistryArticle

Sustainable Development Goals

SDG 0: Good health and well-being

Safety and implementation of a phase 1 randomized GLA-SE-adjuvanted CH505TF gp120 HIV vaccine trial in newborns

FAIR Checklist

DataRank Breakdown

Top 2 citers driving the network score

Authors (23)

Funding (11 grants)

Open Access

Topics

Annotations (Europe PMC)